Evaluation of quantitative IFN-γ response for risk stratification of active tuberculosis suspects

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 1, 2010, Pages 87-93

  Metcalfe, John Z ^a   Cattamanchi, Adithya ^a   Vittinghoff, Eric ^b   Ho, Christine ^c,d   Grinsdale, Jennifer ^c   Hopewell, Philip C ^a,c   Kawamura, L Masae ^c   Nahid, Payam ^a,c  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Division of Tuberculosis Control   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Interferon gamma release assay; Quantiferon; Risk prediction; Risk reclassification

Indexed keywords

GAMMA INTERFERON;

ACID FAST BACTERIUM; ADULT; ARTICLE; ASSAY; BACTERIUM CULTURE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE PREDISPOSITION; FEMALE; HOMELESSNESS; HUMAN; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SILICOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; AGED; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUBERCULOSIS;

EID: 73849138614     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200906-0981OC     Document Type: Article

References (34)

1. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354.
2. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184.
3. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-1173.
4. Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Corrah T, Adegbola RA, et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005;40: 273-278.
5. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006;7:77.
6. KangYA,LeeHW,YoonHI,ChoB,Han SK, ShimYS,YimJJ. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-2761.
7. Diel R, Ernst M, Doscher G, Visuri-Karbe L, Greinert U, Niemann S, Nienhaus A, Lange C. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J 2006;28:16-23.
8. Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I. Rates of latent tuberculosis in health care staff in Russia. PLoS Med 2007;4:e55.
9. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005 Dec 16;54(RR-15):49-55.
10. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a wholeblood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007;44:69-73.
11. Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, Varia H, Millington KA, Gunatheesan R, Guyot-Revol V, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008;148:325-336.
12. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ. Usefulness of whole-blood interferon-gamma assay and interferongamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132:959-965.
13. Kobashi Y, Mouri K, Yagi S, Obase Y, Fukuda M, Miyashita N, Oka M. Usefulness of the Quantiferon TB-2G test for the differential diagnosis of pulmonary tuberculosis. Intern Med 2008;47:237-243.
14. Nishimura T, Hasegawa N, Mori M, Takebayashi T, Harada N, Higuchi K, Tasaka S, Ishizaka A. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:269-274.
15. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, Kok-Jensen A, Andersen P, Weldingh K. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005;12:491-496.
16. Winqvist N, Bjorkman P, Noren A, Miorner H. Use of a T-cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis 2009; 9:105.
17. Goletti D, Stefania C, Butera O, Amicosante M, ErnstM, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TB net-study. PLoS One 2008;3:e3417.
18. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion 207-212.
19. Metcalfe JZ, Cattamanchi A, Ho C, Grinsdale J, Kawamura M. Quantitative interferon-gamma release and classification of tuberculosis suspects with "negative" Quantiferon-Gold results. Am J Respir Crit Care Med 2009;179:A5920.
20. American Thoracic Association and Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. Official Statement of the ATS and CDC, July 1999. Am J Respir Crit Care Med 2000;161:S221-S247.
21. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-1090.
22. Marais BJ, Gie RP, Hesseling AH, Beyers N. Adult-type pulmonary tuberculosis in children 10-14 years of age. Pediatr Infect Dis J 2005; 24:743-744.
23. QuantiFERON-TB Gold: the whole blood IFN-gamma test measuring responses to ESAT-6 & CFP-10 peptide antigens [package insert]. Carnegie, Australia: Cellestis Ltd.; 2007. Doc No. 05980000D. Accessed 2009 Oct 28. Available from: http://www.cellestis.com/IRM/Company/ShowPage.aspx?CPID=1247
24. Sinisi SE, van der Laan MJ. Deletion/substitution/addition algorithm in learning with applications in genomics. Stat Appl Genet Mol Biol 2004;3:Article18.
25. Parker CB, DeLong ER. ROC methodology within a monitoring framework. Stat Med 2003;22:3473-3488.
26. Greenland P, O'Malley PG. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and Creactive protein for stroke risk. Arch Intern Med 2005;165:2454-2456.
27. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847.
28. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
29. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-935.
30. Diverse Populations Collaborative Group. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Heart 2002;88:222-228.
31. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 2008;12: 50-56.
32. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, et al. Comparison of two commercial interferongamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30.
33. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006;25: 127-141.
34. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 2008;149:751-760.